Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: A decision and cost analysis

Clinical Infectious Diseases

Volumn 33, Issue 5, 2001, Pages 615-621

  Le, T P ^a   Miller, L G ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; GENERIC DRUG; MICONAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; COMMUNICABLE DISEASE; COST BENEFIT ANALYSIS; COST MINIMIZATION ANALYSIS; DECISION THEORY; ESCHERICHIA COLI; HUMAN; INFECTION COMPLICATION; INFECTION RESISTANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT PLANNING; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, URINARY; COMPUTER SIMULATION; COST SAVINGS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DECISION SUPPORT TECHNIQUES; DECISION TREES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; PRACTICE GUIDELINES; TRIMETHOPRIM RESISTANCE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS;

EID: 0035451129     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322603     Document Type: Article

References (52)

1. National Ambulatory Medical Care Survey: 1991 summary
2. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women
3. Uncomplicating urinary tract infections
4. The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women
5. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women
6. Measuring costs in cost-utility analyses. Variations in the literature
7. Management of lower urinary tract infections and cystitis
8. Practice guidelines for urinary tract infection in the era of managed care
9. Diagnosis and treatment of uncomplicated urinary tract infection
10. Association of acute cystitis with the stage of the menstrual cycle in young women
11. Management of acute dysuria. A decision-analysis model of alternative strategies
12. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis
13. Advances in the understanding and treatment of urinary tract infections in young women
14. Urinary tract infections in women: Diagnosis and treatment
15. Symptomatic urinary tract infection in women in primary health care. Bacteriological, clinical and diagnostic aspects in relation to host response to infection
16. Short-term treatment of uncomplicated lower urinary tract infections in women
17. Obstetric risk factors for periventricular leukomalacia among preterm infants
18. Realizing the potential of clinical judgment: A real-time strategy for predicting outcomes and cost for medical inpatients
19. The choice of antibacterial drugs
20. Intravenous-to-oral antibiotic switch therapy: A cost-effective approach
21. Pharmacoeconomics of treating uncomplicated urinary tract infections
22. Realizing the potential of clinical judgment: A real-time strategy for predicting outcomes and cost for medical inpatients
23. Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women
24. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial
25. The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women
26. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women
27. Evaluation of suspected urinary tract infection in ambulatory women: A cost-utility analysis of office-based strategies
28. Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women
29. Antibiotic resistance in community-acquired urinary tract infections
30. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
31. Resistance in Campylobacter species: Increased resistance to fluoroquinolones and seasonal variation
32. Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance
33. Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
34. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women
35. Efficacy and safety of ciprofloxacin oral suspension vs. TMP/SMX for treatment of community and nursing home-residing elderly women with acute urinary tract infection (AGS Presidential Poster Session)
36. Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response
37. Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid
38. Comparative anti-microbial resistance and genomic diversity of Escherichia coli isolated from urinary tract infections in the community and in hospitals
39. Urinary tract infections in adults
40. Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992
41. A comparative study of ciprofloxacin and trimethoprim in the treatment of urinary tract infections in geriatric patients
42. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection
43. Ciprofloxacin versus trimethoprim-sulfamethoxazole: Treatment of community-acquired urinary tract infections in a prospective, controlled, double-blind comparison
44. Comparative studies of fluoroquinolones in the treatment of urinary tract infections
45. Treatment of serious urinary tract infections at a university teaching hospital: A retrospective chart review
46. Acute pyelonephritis in women. Short-term hospitalization
47. Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis
48. Serum versus urinary antimicrobial concentrations in cure of urinary tract infections